Further data mining revealed CD106 (VCAM1) in particular promising novel immunotherapeutic target. »
10/11/22

MiR-130b-3p levels significantly upregulated and positively correlated with mTORC1 signaling in multiple cancers. »
10/11/22

Severe risk of false positive outliers in current DL predictions. »
10/22/22

Middle-aged and older cancer survivors at significantly higher risk of experiencing poor self-reported health. »
10/22/22

Single-cell RNA sequencing data evidenced induction of pro-inflammatory phenotype in CAFs. »
10/22/22

Discrimination of PredictCBC-2.0 at 10 years higher than PredictCBC. »
10/21/22

Various ICRs found to be highly co-expressed with each other. »
10/21/22

Combined targeted drug and immunotherapy significantly improved survival. »
10/21/22

MET-CAR-T exerted specific cytotoxic activity against MET expressing cells. »
10/21/22

Higher percentage of clearance of PAP-smear abnormalities in patients who took long term oral Lactobacillus crispatus. »
10/21/22